Oxford researchers accused of giving babies unsafe TB drug


A team of Oxford University researchers have been accused of deception and misconduct during a large-scale tuberculosis trial on African infants that began in 2009.

Professor Peter Beverley, a former senior academic at Oxford, told the BBC that scientists tested a new tuberculosis vaccine on more than a thousand infants without sharing data suggesting that monkeys given the immunisation “die rapidly”.

According to Beverley, the new vaccine, known as MVA85A, was trialled on six monkeys 10 months before a funding application was made for the clinical trial on over 2,800 babies near Cape Town, South Africa.

The preclinical monkey trial involved over a dozen monkeys who had been infected with TB. One group was given the widely used Bacillus Calmette-Guérin (BCG) jab (a standard immunisation), the second was given no immunisation and a third was given BCG plus new vaccine. By the time the human trials began, five out of six of those that received the BCG jab and the new booster vaccine together had to be put down, while just two out of the six monkeys who received only the BCG injection had died.

Despite this, an information sheet given to families in South Africa participating in the trial said the vaccine had been tested on animals and humans and was “safe and effective” in animals.  

An inquiry at the University found that there had been no wrongdoing, though the report stated that it “would have been good practice for the potentially adverse reaction observed in the monkey experiment to be reported to the authorities in a more timely fashion.”




MORE ON THESE TOPICS | deception, informed consent, research ethics, vaccination

This article is published by Xavier Symons and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 
comments powered by Disqus